ORV of wildlife has had positive public health effects. Multiyear campaigns have led to progressive elimination of arctic fox–variant and canine-variant rabies in Ontario and Texas, respectively. PIC, TVR, and ORV zones have prevented raccoon-variant rabies from becoming established in Ontario. Campaigns to contain and eliminate rabies in gray foxes of west-central Texas continue, and spillover of gray fox–variant rabies into coyotes may pose new challenges for preventing the spread of this variant. The ORV zones and contingency actions along the Appalachian Ridge have, thus far, prevented westward spread of raccoon rabies. Habitat alterations to reduce potential carrying capacities of raccoons through local no-feeding regulations and improved refuse management would aid rabies control efforts, but these measures are difficult to implement and enforce. Improved bait-vaccine technology, potentially integrating reproductive inhibitors into TVR campaigns for specific urban raccoon and skunk populations, may improve wildlife rabies elimination. Rabies campaigns have been relatively expensive. We estimate that >$130 million (combined Can$ and US$) has been spent on ORV programs in North America during the past 10 years. Programs have proved lengthy (typically >5 years), have required enhanced surveillance, and have often required contingency actions to ensure rabies elimination without reintroduction. Most economic assessments and modeling studies indicate that ORV programs can yield cost savings (32–35). Regional increases in PEP administrations (and associated public health costs) from 2–4/100,000 before to 24/100,000 (30), 45/100,000 (28), or 66/100,000 (27) residents during or after have been documented for nonbat rabies epizootics. Reduced PEP, epizootic-related pet vaccinations, animal diagnostic tests, public education activities, and other factors represent costs avoided by ORV programs. Direct estimates of wild mammal populations and the relationship of these to numbers of PEP administrations are difficult to obtain; this topic was beyond the scope of our review but needs research.
Emerging Infectious Diseases
August 25, 2009
Original web page at Emerging Infectious Diseases



